Green Cross Medical Science Corporation (142280) — Cash Flow-to-Debt Ratio
Green Cross Medical Science Corporation (142280) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of ₩-160.64 Million could theoretically repay 0% of its total liabilities (₩44.56 Billion) in one year. Explore 142280 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Green Cross Medical Science Corporation Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Green Cross Medical Science Corporation across 12 annual periods. Also explore how large is Green Cross Medical Science Corporation's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Green Cross Medical Science Corporation (2014–2025)
Year-by-year debt coverage analysis for Green Cross Medical Science Corporation. For market capitalisation and broader financial context, see Green Cross Medical Science Corporation (142280) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₩7.20 Billion | ₩44.14 Billion | ▲ +108.2% |
| 2024 | 0.08x | ₩3.66 Billion | ₩46.76 Billion | ▼ -1.0% |
| 2023 | 0.08x | ₩4.24 Billion | ₩53.61 Billion | ▼ -54.0% |
| 2022 | 0.17x | ₩10.88 Billion | ₩63.22 Billion | ▲ +156.3% |
| 2021 | -0.31x | ₩-18.20 Billion | ₩59.51 Billion | ▼ -71.5% |
| 2020 | -0.18x | ₩-8.76 Billion | ₩49.14 Billion | ▼ -70.5% |
| 2019 | -0.10x | ₩-4.11 Billion | ₩39.29 Billion | ▼ -884.2% |
| 2018 | -0.01x | ₩-516.61 Million | ₩48.63 Billion | ▼ -112.8% |
| 2017 | 0.08x | ₩3.11 Billion | ₩37.31 Billion | ▼ -70.1% |
| 2016 | 0.28x | ₩10.25 Billion | ₩36.76 Billion | ▲ +323.9% |
| 2015 | -0.12x | ₩-5.45 Billion | ₩43.74 Billion | ▼ -15.6% |
| 2014 | -0.11x | ₩-2.22 Billion | ₩20.60 Billion | — |